Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

@inproceedings{Watts1991IntermittentCE,
  title={Intermittent cyclical etidronate treatment of postmenopausal osteoporosis},
  author={Nelson B. Watts and Steven T. Harris and Harry K. Genant and Richard D. Wasnich and Paul D. Miller and Rebecca D. Jackson and Angelo A. Licata and Philip D. Ross and Grattan C. Woodson and Melissa J. Yanover and W. Jerry Mysiw and L. M. Kohse and Marepalli B. Rao and Peter Steiger and Bradford Richmond and Charles W. Chesnut},
  year={1991}
}

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 263 CITATIONS, ESTIMATED 61% COVERAGE

Clinical trial of risedronate in Japanese volunteers: single and multiple oral dose studies

  • Journal of Bone and Mineral Metabolism
  • 2003
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Calcitonin versus etidronate for the treatment of postmenopausal osteoporosis: A meta-analysis of published clinical trials

  • Osteoporosis International
  • 1997
VIEW 5 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

Clinical experience with etidronate in osteoporosis

  • Clinical Rheumatology
  • 1994
VIEW 4 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

The effect of treatment with calcitonin on vertebral fracture rate in osteoporosis

  • Osteoporosis International
  • 1993
VIEW 9 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Cyclic oral phosphate and etidronate increase femoral and lumbar bone mineral density and reduce lumbar spine fracture rate over three years.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 1992
VIEW 7 EXCERPTS
CITES BACKGROUND, RESULTS & METHODS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

1990
2019

CITATION STATISTICS

  • 20 Highly Influenced Citations